Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Giannis M"'
Publikováno v:
NCSL International measure. 13:58-69
Facilitating the uptake of established methodologies for risk-based decision-making in product conformity assessment taking into account measurement uncertainty by providing dedicated software is the aim of the European project EMPIR CASoft(2018–20
Autor:
Yoo, Hyeonji1 (AUTHOR), Kim, Yeonjin1 (AUTHOR), Kim, Jinseong1 (AUTHOR) mary927@ewhain.net, Cho, Hanhee1 (AUTHOR), Kim, Kwangmeyung1 (AUTHOR) kimkm@ewha.ac.kr
Publikováno v:
Molecules. Sep2024, Vol. 29 Issue 17, p3994. 20p.
Autor:
Patterson CM; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield, SK10 2NA, UK., Balachander SB; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Grant I; Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, SK10 2NA, UK., Pop-Damkov P; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Kelly B; Starpharma, 4-6 Southampton Crescent, Abbotsford, VIC, 3067, Australia., McCoull W; Oncology R&D, AstraZeneca, Cambridge, CB4 0FZ, UK., Parker J; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield, SK10 2NA, UK., Giannis M; Starpharma, 4-6 Southampton Crescent, Abbotsford, VIC, 3067, Australia., Hill KJ; Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, SK10 2NA, UK., Gibbons FD; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Hennessy EJ; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Kemmitt P; Oncology R&D, AstraZeneca, Cambridge, CB4 0FZ, UK., Harmer AR; Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, CB4 0FZ, UK., Gales S; Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, CB4 0FZ, UK., Purbrick S; Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, CB4 0FZ, UK., Redmond S; Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Boston, MA, 02451, USA., Skinner M; Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, CB4 0FZ, UK., Graham L; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield, SK10 2NA, UK., Secrist JP; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Schuller AG; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Wen S; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Adam A; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Reimer C; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Cidado J; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Wild M; Oncology R&D, AstraZeneca, Cambridge, CB4 0FZ, UK., Gangl E; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Fawell SE; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Saeh J; Oncology R&D, AstraZeneca, Boston, MA, 02451, USA., Davies BR; Oncology R&D, AstraZeneca, Cambridge, CB4 0FZ, UK., Owen DJ; Starpharma, 4-6 Southampton Crescent, Abbotsford, VIC, 3067, Australia., Ashford MB; Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield, SK10 2NA, UK. Marianne.Ashford@astrazeneca.com.
Publikováno v:
Communications biology [Commun Biol] 2021 Jan 25; Vol. 4 (1), pp. 112. Date of Electronic Publication: 2021 Jan 25.
Autor:
Sarma, Kangkan1 (AUTHOR) sarma_kangkan@outlook.com, Akther, Md Habban1 (AUTHOR) 1000015383@dit.edu.in, Ahmad, Irfan2 (AUTHOR) habban.akhter@dituniversity.edu.in, Afzal, Obaid3 (AUTHOR) o.akram@psau.edu.sa, Altamimi, Abdulmalik S. A.3 (AUTHOR) as.altamimi@psau.edu.sa, Alossaimi, Manal A.3 (AUTHOR) m.alossaimi@psau.edu.sa, Jaremko, Mariusz4 (AUTHOR) mariusz.jaremko@kaust.edu.sa, Emwas, Abdul-Hamid5 (AUTHOR) abdelhamid.emwas@kaust.edu.sa, Gautam, Preety1 (AUTHOR)
Publikováno v:
Molecules. Mar2024, Vol. 29 Issue 5, p1076. 51p.
Autor:
Kleber, Martina1,2 (AUTHOR) martina.kleber@hirslanden.ch, Ntanasis-Stathopoulos, Ioannis3 (AUTHOR), Terpos, Evangelos3 (AUTHOR) eterpos@med.uoa.gr
Publikováno v:
Cancers. Dec2023, Vol. 15 Issue 24, p5829. 15p.
Autor:
Xu, Jiaxuan1 (AUTHOR) jiaxuanxu@smail.nju.edu.cn, Dong, Xiaoqing1 (AUTHOR) qgswns@126.com, Huang, David C. S.2,3 (AUTHOR) huang_d@wehi.edu.au, Xu, Peipei1 (AUTHOR) xu_peipei0618@163.com, Zhao, Quan1 (AUTHOR) qzhao@nju.edu.cn, Chen, Bing1 (AUTHOR) qzhao@nju.edu.cn
Publikováno v:
Cancers. Oct2023, Vol. 15 Issue 20, p4957. 24p.
Autor:
Throup, Adam, Zraikat, Manar Saleh, Gordon, Andrew, Soumehsaraei, Shohreh Jafarinejad, Haase, Kathrin D., Patterson, Laurence H., Cooper, Patricia A., Hanlon, Katherine, Loadman, Paul M., Sutherland, Mark, Shnyder, Steven D., Sheldrake, Helen M.
Publikováno v:
RSC Medicinal Chemistry; Oct2024, Vol. 15 Issue 10, p3616-3624, 9p
Autor:
McCarthy, T. D., Karellas, P., Henderson, S. A., Giannis, M., O'Keefe, D. F., Heery, G., Paull, J. R. A., Matthews, B. R., Holan, G.
Publikováno v:
Molecular Pharmaceutics; August 2005, Vol. 2 Issue: 4 p312-318, 7p
Autor:
Kisakova, Lyubov A.1 (AUTHOR) orlova.lyub1996@yandex.ru, Apartsin, Evgeny K.2 (AUTHOR) evgeny.apartsin@u-bordeaux.fr, Nizolenko, Lily F.1 (AUTHOR) nizolenko@inbox.ru, Karpenko, Larisa I.1 (AUTHOR) evgeny.apartsin@u-bordeaux.fr
Publikováno v:
Pharmaceutics. Apr2023, Vol. 15 Issue 4, p1106. 38p.
Autor:
Moreira, Débora A.1,2,3 (AUTHOR), Santos, Sofia D.1,2 (AUTHOR), Leiro, Victoria1,2 (AUTHOR) victoria.leiro@ineb.up.pt, Pêgo, Ana P.1,2,4 (AUTHOR) victoria.leiro@ineb.up.pt
Publikováno v:
Pharmaceutics. Apr2023, Vol. 15 Issue 4, p1054. 60p.